CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07492680
- Title field or adapter rule
- {'original_value': 'A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:23.981768+00:00
- Published At
- 2026-10-06T00:00:00+00:00
- Record Updated At
- 2026-10-06
- Source Retrieved At
- 2026-10-31T22:17:54.613222+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Solid Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-06", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT07492680"- protocolSection.identificationModule.officialTitle
"A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Part 1a', 'Part 1b', 'Part 2: Cohort 1', 'Part 2: Cohort 2a', 'Part 2: Cohort 2b', 'Part 2: Cohort 2c', 'Part 2: Cohort 3', 'Part 2: Cohort 4'], 'description': 'Specified dose on specified days', 'name': 'BMS-986504', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 2a', 'Part 2: Cohort 2b', 'Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Daraxonrasib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 3'], 'description': 'Specified dose on specified days', 'name': 'Nivolumab + Relatlimab FDC', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 4'], 'description': 'Specified dose on specified days', 'name': 'Temozolomide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Pumitamig', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Pemetrexed', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 1', 'Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
Drug names recorded in this source
A recorded drug name is not by itself an indication or a condition-specific relationship.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.